Overview

Practicability and Acceptability of Stylomax® in Children

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Primary objective: to evaluate the practicability and acceptability of STYLOMAX®, a new injection device for MAXOMAT®, in children, for 1 year.
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi